Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | VEGF | 751.0 | 58 | |
| N2586 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | VEGF | 574.5 | 50 | |
| N2586 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | VEGF | 539.0 | 59 | |
| N2586 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 1 | VEGF | 666.0 | 51 | |
| RA2159 | Leptin | 1 | ng/mL | 1 | VEGF | 693.0 | 57 | ||||
| RA2159 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 1 | VEGF | 744.5 | 46 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | VEGF | 777.0 | 63 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | VEGF | 643.0 | 63 | |
| RA2159 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | VEGF | 624.5 | 50 | |
| RA2159 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 1 | VEGF | 601.0 | 77 | |
| N2586 | Leptin | 1 | ng/mL | 1 | VEGF | 1118.0 | 55 | ||||
| N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 1 | VEGF | 1015.5 | 46 | |
| N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | VEGF | 951.0 | 47 | |
| N2586 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | VEGF | 646.5 | 64 | |
| N2586 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | VEGF | 833.0 | 57 | |
| N2586 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 1 | VEGF | 1037.0 | 35 | |
| RA2159 | 1 | VEGF | 715.0 | 51 | |||||||
| RA2159 | PD184352 | 0.1 | uM | 1 | VEGF | 1099.0 | 81 | ||||
| RA2159 | Lestaurtinib | 0.3 | uM | 1 | VEGF | 745.0 | 65 | ||||
| RA2159 | Ruxolitinib | 0.3 | uM | 1 | VEGF | 983.0 | 50 | ||||
| RA2159 | Tofacitinib | 0.3 | uM | 1 | VEGF | 748.0 | 66 | ||||
| RA2159 | IKK16 | 2.0 | uM | 1 | VEGF | 716.5 | 70 | ||||
| RA2159 | 1 | VEGF | 689.0 | 69 | |||||||
| N2586 | 1 | VEGF | 1211.0 | 61 | |||||||
| N2586 | PD184352 | 0.1 | uM | 1 | VEGF | 1122.5 | 60 |